Detalhe da pesquisa
1.
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
N Engl J Med
; 390(2): 132-142, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197816
2.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
N Engl J Med
; 389(17): 1553-1565, 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37888916
3.
Emerging Role of Scintigraphy Using Bone-Seeking Tracers for Diagnosis of Cardiac Amyloidosis: AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 222(1): e2329347, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315017
4.
18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.
J Nucl Cardiol
; 30(2): 726-735, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084701
5.
Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directions.
Clin Adv Hematol Oncol
; 20(10): 609-618, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206073
6.
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
Eur Heart J
; 42(16): 1554-1568, 2021 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825853
7.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
N Engl J Med
; 379(11): 1007-1016, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145929
8.
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Circulation
; 139(4): 431-443, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586695
9.
Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications.
Mod Pathol
; 33(5): 764-774, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723241
10.
Transthyretin amyloidosis: Putting myopathy on the map.
Muscle Nerve
; 61(1): 95-100, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587306
11.
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiovasc Drugs Ther
; 34(6): 889, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548685
12.
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiovasc Drugs Ther
; 34(3): 357-370, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062791
13.
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
BMC Fam Pract
; 21(1): 198, 2020 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967612
14.
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.
Br J Haematol
; 187(5): 588-594, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298751
15.
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.
Blood
; 129(15): 2111-2119, 2017 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126928
16.
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Circulation
; 133(24): 2404-12, 2016 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143678
17.
Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis.
J Magn Reson Imaging
; 46(5): 1361-1367, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236336
18.
Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
Prog Transplant
; 27(3): 246-250, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29187090
19.
LMNA-Mediated Arrhythmogenic Right Ventricular Cardiomyopathy and Charcot-Marie-Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis.
J Cardiovasc Electrophysiol
; 27(7): 868-71, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405450
20.
Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.
J Cardiovasc Electrophysiol
; 27(10): 1167-1173, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422772